Top

Published in:

01-12-2018 | Clinical Study

Stereotactic radiosurgery for hypervascular intracranial tumors

Authors: Cheng-Chia Lee, Chun-Lung Chou, Ching-Jen Chen, Huai-Che Yang, Hsiu-Mei Wu, Cheng-Ying Shiau, David Hung-Chi Pan, Wen-Yuh Chung

Published in: Journal of Neuro-Oncology | Issue 3/2018

Abstract

Objective

To evaluate the safety and efficacy of SRS treatment of central neurocytomas (CNCs), cavernous sinus hemangiomas (CSHs), and glomus tumors (GTs); and to compare upfront stereotactic radiosurgery (SRS) and adjuvant SRS in the treatment of these hypervascular tumors.

Methods

This was a retrospective review of consecutive CNCs, CSHs, and GTs treated with SRS between 1993 and 2017. Tumor response was categorized based on volumetric analysis on magnetic resonance imaging: (1) tumor regression [> 10% decrease in tumor volume (TV)]; (2) stable tumor (≤ 10% change in TV); or (3) tumor progression (> 10% increase in TV).

Results

Sixty hypervascular tumors (CNC: 28; CSH: 16; GT: 16) underwent SRS between 1993 and 2017. Margin doses were 13 Gy, 12 Gy, and 14 Gy for CNCs, CSHs, and GTs, respectively. Tumor regression was observed in 54 tumors (90%) with initial SRS after a median follow-up of 82 months. Relative reductions in TVs for CNCs were 38%, 52%, and 73% at 12, 24, and 48 months, respectively. Relative reductions in TVs for CSHs were 51%, 68%, and 88% at 12, 24, and 48 months, respectively. Relative reductions in TVs for GTs were 22%, 31%, and 47% at 12, 24, and 48 months, respectively. Upfront SRS was performed in 26 patients (43%). No difference in relative TV reductions were found between upfront and adjuvant SRS. Adverse radiation effects were observed in five patients. No mortality was encountered.

Conclusion

SRS for hypervascular tumors is associated with high rates of tumor regression with low risk of complications. No significant difference in rates of relative TV reduction were found between upfront and adjuvant SRS. Hence, upfront SRS may be considered in select patients.

Razzaq AA, Cohen AR (1997) Neoadjuvant chemotherapy for hypervascular malignant brain tumors of childhood. Pediatr Neurosurg 27:296–303. https://doi.org/10.1159/000121274 CrossRefPubMed

Chen CL, Shen CC, Wang J, Lu CH, Lee HT (2008) Central neurocytoma: a clinical, radiological and pathological study of nine cases. Clin Neurol Neurosurg 110:129–136. https://doi.org/10.1016/j.clineuro.2007.09.023 CrossRefPubMed

Jaiswal S, Vij M, Rajput D, Mehrotra A, Jaiswal AK, Srivastava AK, Behari S, Krishnani N (2011) A clinicopathological, immunohistochemical and neuroradiological study of eight patients with central neurocytoma. J Clin Neurosci 18:334–339. https://doi.org/10.1016/j.jocn.2010.05.031 CrossRefPubMed

Kocaoglu M, Ors F, Bulakbasi N, Onguru O, Ulutin C, Secer HI (2009) Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings. Magn Reson Imaging 27:434–440. https://doi.org/10.1016/j.mri.2008.07.012 CrossRefPubMed

Lee CC, Pan DH, Wu JC, Chung WY, Wu HM, Yang HC, Liu KD, Guo WY, Shih YH (2011) Gamma knife radiosurgery for glomus jugulare and tympanicum. Stereotact Funct Neurosurg 89:291–298. https://doi.org/10.1159/000328890 CrossRefPubMed

Lee CC, Sheehan JP, Kano H, Akpinar B, Martinez-Alvarez R, Martinez-Moreno N, Guo WY, Lunsford LD, Liu KD (2017) Gamma Knife radiosurgery for hemangioma of the cavernous sinus. J Neurosurg 126:1498–1505. https://doi.org/10.3171/2016.4.JNS152097 CrossRefPubMed

Shah T, Jayasundar R, Singh VP, Sarkar C (2011) MRS characterization of central neurocytomas using glycine. NMR Biomed 24:1408–1413. https://doi.org/10.1002/nbm.1705 CrossRefPubMed

Tlili-Graiess K, Mama N, Arifa N, Kadri K, Hasni I, Krifa H, Mokni M (2014) Diffusion weighted MR imaging and proton MR spectroscopy findings of central neurocytoma with pathological correlation. J Neuroradiol 41:243–250. https://doi.org/10.1016/j.neurad.2013.09.004 CrossRefPubMed

Karlsson B, Guo WY, Kejia T, Dinesh N, Pan DH, Jokura H, Kawagishi J, van Eck AT, Horstmann GA, Yeo TT, Yamamoto M (2012) Gamma Knife surgery for central neurocytomas. J Neurosurg 117:96–101. https://doi.org/10.3171/2012.6.GKS12214 CrossRefPubMed

10.

Wichmann W, Schubiger O, von Deimling A, Schenker C, Valavanis A (1991) Neuroradiology of central neurocytoma. Neuroradiology 33:143–148CrossRefPubMed

11.

Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neuro-oncol 66:377–384CrossRef

12.

Choudhari KA, Kaliaperumal C, Jain A, Sarkar C, Soo MY, Rades D, Singh J (2009) Central neurocytoma: a multi-disciplinary review. Br J Neurosurg 23:585–595. https://doi.org/10.3109/02688690903254350 CrossRefPubMed

13.

Lombardi D, Giovanelli M, de Tribolet N (1994) Sellar and parasellar extra-axial cavernous hemangiomas. Acta Neurochir 130:47–54CrossRefPubMed

14.

Yao Z, Feng X, Chen X, Zee C (2006) Magnetic resonance imaging characteristics with pathological correlation of cavernous malformation in cavernous sinus. J Comput Assist Tomogr 30:975–979. https://doi.org/10.1097/01.rct.0000221953.06135.3e CrossRefPubMed

15.

Suzuki Y, Shibuya M, Baskaya MK, Takakura S, Yamamoto M, Saito K, Glazier SS, Sugita K (1996) Extracerebral cavernous angiomas of the cavernous sinus in the middle fossa. Surg Neurol 45:123–132CrossRefPubMed

16.

Ivanov P, Chernov M, Hayashi M, Nakaya K, Izawa M, Murata N, Kubo O, Ujiie H, Muragaki Y, Nakamura R, Iseki H, Hori T, Takakura K (2008) Low-dose gamma knife radiosurgery for cavernous sinus hemangioma: report of 3 cases and literature review. Minim Invasive Neurosurg 51:140–146. https://doi.org/10.1055/s-2008-1065346 CrossRefPubMed

17.

Rao AB, Koeller KK, Adair CF (1999) From the archives of the AFIP. Paragangliomas of the head and neck: radiologic-pathologic correlation. Armed Forces Inst Pathol Radiogr 19:1605–1632. https://doi.org/10.1148/radiographics.19.6.g99no251605 CrossRef

18.

Vogl T, Bruning R, Schedel H, Kang K, Grevers G, Hahn D, Lissner J (1989) Paragangliomas of the jugular bulb and carotid body: MR imaging with short sequences and Gd-DTPA enhancement. AJR Am J Roentgenol 153:583–587. https://doi.org/10.2214/ajr.153.3.583 CrossRefPubMed

19.

Snell JW, Sheehan J, Stroila M, Steiner L (2006) Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104:157–162. https://doi.org/10.3171/jns.2006.104.1.157 CrossRefPubMed

20.

Devuyst L, Defreyne L, Praet M, Geukens S, Dhooge I (2016) Treatment of glomus tympanicum tumors by preoperative embolization and total surgical resection. Am J Otolaryngol 37:544–551. https://doi.org/10.1016/j.amjoto.2016.08.011 CrossRefPubMed

21.

Tasar M, Yetiser S (2004) Glomus tumors: therapeutic role of selective embolization. J Craniofac Surg 15:497–505CrossRefPubMed

22.

Lazzaro MA, Badruddin A, Zaidat OO, Darkhabani Z, Pandya DJ, Lynch JR (2011) Endovascular embolization of head and neck tumors. Front Neurol 2:64. https://doi.org/10.3389/fneur.2011.00064 CrossRefPubMedPubMedCentral

23.

Kamitani H, Hirano N, Takigawa H, Yokota M, Miyata H, Ohama E, Watanabe T (2004) Attenuation of vascularity by preoperative radiosurgery facilitates total removal of a hypervascular hemangioblastoma at the cerebello-pontine angle: case report. Surg Neurol 62:238–243. https://doi.org/10.1016/j.surneu.2003.09.030 (discussion 243–234)CrossRefPubMed

24.

Song CW, Park H, Griffin RJ, Levitt SH (2011) Radiobiology of stereotactic radiosurgery and stereotactic body radiation therapy. Springer, HeidelbergCrossRef

25.

Song CW, Levitt SH (1971) Vascular changes in Walker 256 carcinoma of rats following X irradiation. Radiology 100:397–407. https://doi.org/10.1148/100.2.397 CrossRefPubMed

26.

Song CW, Payne JT, Levitt SH (1972) Vascularity and blood flow in X-irradiated Walker carcinoma 256 of rats. Radiology 104:693–697. https://doi.org/10.1148/104.3.693 CrossRefPubMed

27.

Song CW, Sung JH, Clement JJ, Levitt SH (1974) Vascular changes in neuroblastoma of mice following x-irradiation. Cancer Res 34:2344–2350PubMed

28.

Cohen-Inbar O, Lee CC, Sheehan JP (2016) The contemporary role of stereotactic radiosurgery in the treatment of meningiomas. Neurosurg Clin N Am 27:215–228. https://doi.org/10.1016/j.nec.2015.11.006 CrossRefPubMed

29.

Lee CC, Trifiletti DM, Sahgal A, DeSalles A, Fariselli L, Hayashi M, Levivier M, Ma L, Alvarez RM, Paddick I, Regis J, Ryu S, Slotman B, Sheehan J (2018) Stereotactic Radiosurgery for Benign (World Health Organization Grade I) Cavernous Sinus Meningiomas-International Stereotactic Radiosurgery Society (ISRS) Practice Guideline: a systematic review. Neurosurgery. https://doi.org/10.1093/neuros/nyy009 CrossRefPubMed

30.

Song CW, Cho LC, Yuan J, Dusenbery KE, Griffin RJ, Levitt SH (2013) Radiobiology of stereotactic body radiation therapy/stereotactic radiosurgery and the linear-quadratic model. Int J Radiat Oncol Biol Phys 87:18–19. https://doi.org/10.1016/j.ijrobp.2013.03.013 CrossRefPubMed

31.

Chou CW, Wu HM, Huang CI, Chung WY, Guo WY, Shih YH, Lee LS, Pan DH (2010) Gamma knife surgery for cavernous hemangiomas in the cavernous sinus. Neurosurgery 67:611–616. https://doi.org/10.1227/01.NEU.0000378026.23116.E6 (discussion 616)CrossRefPubMed

32.

Iwai Y, Yamanaka K, Nakajima H, Yasui T (1999) Stereotactic radiosurgery for cavernous sinus cavernous hemangioma—case report. Neurol Med Chir 39:288–290 p doCrossRef

33.

Kida Y, Kobayashi T, Mori Y (2001) Radiosurgery of cavernous hemangiomas in the cavernous sinus. Surg Neurol 56:117–122 (discussion 122–113)CrossRefPubMed

34.

Seo Y, Fukuoka S, Sasaki T, Takanashi M, Hojo A, Nakamura H (2000) Cavernous sinus hemangioma treated with gamma knife radiosurgery: usefulness of SPECT for diagnosis—case report. Neurol Med Chir 40:575–580CrossRef

35.

Thompson TP, Lunsford LD, Flickinger JC (2000) Radiosurgery for hemangiomas of the cavernous sinus and orbit: technical case report. Neurosurgery 47:778–783PubMed

36.

Zhou LF, Mao Y, Chen L (2003) Diagnosis and surgical treatment of cavernous sinus hemangiomas: an experience of 20 cases. Surg Neurol 60:31–36 (discussion 36–37)CrossRefPubMed

37.

Lubrano V, Francois P, Loundou A, Vasiljevic A, Roche PH, French Society of Neurosurgery (2013) Outcomes after surgery for central neurocytoma: results of a French multicentre retrospective study. Acta Neurochir 155:1261–1269. https://doi.org/10.1007/s00701-013-1732-y CrossRefPubMed

38.

Qian H, Lin S, Zhang M, Cao Y (2012) Surgical management of intraventricular central neurocytoma: 92 cases. Acta Neurochir 154:1951–1960. https://doi.org/10.1007/s00701-012-1446-6 CrossRefPubMed

39.

Rades D, Fehlauer F, Schild SE (2004) Treatment of atypical neurocytomas. Cancer 100:814–817. https://doi.org/10.1002/cncr.20032 CrossRefPubMed

40.

Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neuro-oncol 77:305–309. https://doi.org/10.1007/s11060-005-9047-3 CrossRef

41.

Kim CY, Paek SH, Jeong SS, Chung HT, Han JH, Park CK, Jung HW, Kim DG (2007) Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment. Cancer 110:2276–2284. https://doi.org/10.1002/cncr.23036 CrossRefPubMed

42.

Kim JW, Kim DG, Kim IK, Kim YH, Choi SH, Han JH, Park CK, Chung HT, Park SH, Paek SH, Jung HW (2013) Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years’ experience in a single institute. Neurosurgery 72:407–413. https://doi.org/10.1227/NEU.0b013e3182804662 (discussion 413–404)CrossRefPubMed

43.

Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL, Lee JY, Kano H, Park KJ, Niranjan A, Kondziolka D, Barnett GH, Rush S, Golfinos JG, Lunsford LD (2013) Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg 119:446–456. https://doi.org/10.3171/2013.3.JNS12766 CrossRefPubMed

44.

Lee CC, Chen CJ, Chen SC, Yang HC, Lin CJ, Wu CC, Chung WY, Guo WY, Hung-Chi Pan D, Shiau CY, Wu HM (2017) Gamma Knife surgery for clival epidural-osseous dural arteriovenous fistulas. J Neurosurg. https://doi.org/10.3171/2017.1.JNS161346 CrossRefPubMedPubMedCentral

45.

Mineura K, Sasajima T, Itoh Y, Sasajima H, Kowada M, Tomura N, Uesaka Y, Ogawa T, Hatazawa J, Uemura K (1995) Blood flow and metabolism of central neurocytoma: a positron emission tomography study. Cancer 76:1224–1232CrossRefPubMed

46.

Soni N, Dhanota DPS, Kumar S, Jaiswal AK, Srivastava AK (2017) Perfusion MR imaging of enhancing brain tumors: comparison of arterial spin labeling technique with dynamic susceptibility contrast technique. Neurol India 65:1046–1052. https://doi.org/10.4103/neuroindia.NI_871_16 CrossRefPubMed

Title: Stereotactic radiosurgery for hypervascular intracranial tumors
Authors: Cheng-Chia Lee
Chun-Lung Chou
Ching-Jen Chen
Huai-Che Yang
Hsiu-Mei Wu
Cheng-Ying Shiau
David Hung-Chi Pan
Wen-Yuh Chung
Publication date: 01-12-2018
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-018-2980-8

At a glance: The STEP trials

Springer Medicine

Stereotactic radiosurgery for hypervascular intracranial tumors

Abstract

Objective

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2018

Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade

Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience

Repeatability of dynamic contrast enhanced vp parameter in healthy subjects and patients with brain tumors

Clinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center study

Acknowledgement of reviewers 2016 and 2017

Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II–IV